MicroRNA works with Ago2 protein to regulate blood cell development

July 26, 2007

MicroRNAs became the stars of the RNA universe when, in 2001, scientists found that these short RNAs can control whether or not genes are expressed. This month, scientists at Rockefeller University and the Wellcome Trust cast new light on the genesis of these key biological regulators and how they carry out their function. These provocative new findings were reported online July 12 in the journal Genes & Development.

While microRNAs are made in large amounts in every cell from plants to humans, Dónal O'Carroll, a research associate in Alexander Tarakhovsky's lab at The Rockefeller University, has focused on understanding how they regulate the development of one particular system: the hematopoietic system.

"This is a system where similar kinds of stem cells give rise to all the different types of blood cells in the body, so you can definitively address whether microRNAs are involved in the processes by which they specialize and develop," says O'Carroll.

Instead of making proteins, these snippets of RNA repress their synthesis. They bind to messenger RNAs (mRNAs) -- the blueprints for proteins -- and either target them for destruction or inhibit their protein-making output. In order for microRNA to find its target mRNA, it needs the help of the protein Ago2, the only member of the Argonaute family of proteins that has a "slicer" function: That is, once microRNA binds with its target, it cleaves it, effectively stopping mRNA's ability to make proteins.

Since the "slicer" activity of Ago2 would be the most efficient way of regulating microRNA function, O'Carroll wanted to see whether it plays a role in the development of blood cells.

In the bone marrow of adult mice -- where their blood stem cells reside -- O'Carroll conditionally knocked out the gene that encodes Ago2. Two months later, O'Carroll observed that they had developed anemia and enlarged spleens, and noted that although the stem cells still gave rise to all blood cell types, the development of two of them was severely affected: B lymphocytes, which contribute to the production of antibodies, and red blood cells.

When he looked at the Ago2-deficient mice's blood cells, he also saw that the microRNA levels, though not zero, were much reduced, indicating that Ago2 is essential for microRNA homeostasis during the early development of blood cells.

To specifically test the importance of Ago2's "slicer" activity, O'Carroll then genetically reconstituted the Ago2-deficient stem cells with either wild type Ago2 or a modified version of it that rendered the "slicer" activity inactive. A few weeks later, both conditions -- the anemia and the enlarged spleen -- in both groups of mice were cured, suggesting that this feature of Ago2 makes only a minor contribution to its biological function. The finding was surprising since the "slicer" function is unique to Ago2.

"At least within this system, 'slicer' activity doesn't have a role in the execution of microRNA function, but Ago2 does have a special role in the maintenance of microRNA levels," says O'Carroll, who recently accepted a position at the European Molecular Biology Laboratory in Rome.

Within the blood system, low levels of microRNA are not life-threatening during development but do have a distinct effect on different blood cell lineages.

"The results have caused us to think about the differential sensitivity of distinct developmental processes to microRNA levels," says Tarakhovsky. "It remains to be seen to what extent specialized functions of developing cells in the blood system depend on microRNA."

Rockefeller University

Related Stem Cells Articles from Brightsurf:

SUTD researchers create heart cells from stem cells using 3D printing
SUTD researchers 3D printed a micro-scaled physical device to demonstrate a new level of control in the directed differentiation of stem cells, enhancing the production of cardiomyocytes.

More selective elimination of leukemia stem cells and blood stem cells
Hematopoietic stem cells from a healthy donor can help patients suffering from acute leukemia.

Computer simulations visualize how DNA is recognized to convert cells into stem cells
Researchers of the Hubrecht Institute (KNAW - The Netherlands) and the Max Planck Institute in Münster (Germany) have revealed how an essential protein helps to activate genomic DNA during the conversion of regular adult human cells into stem cells.

First events in stem cells becoming specialized cells needed for organ development
Cell biologists at the University of Toronto shed light on the very first step stem cells go through to turn into the specialized cells that make up organs.

Surprising research result: All immature cells can develop into stem cells
New sensational study conducted at the University of Copenhagen disproves traditional knowledge of stem cell development.

The development of brain stem cells into new nerve cells and why this can lead to cancer
Stem cells are true Jacks-of-all-trades of our bodies, as they can turn into the many different cell types of all organs.

Healthy blood stem cells have as many DNA mutations as leukemic cells
Researchers from the Princess Máxima Center for Pediatric Oncology have shown that the number of mutations in healthy and leukemic blood stem cells does not differ.

New method grows brain cells from stem cells quickly and efficiently
Researchers at Lund University in Sweden have developed a faster method to generate functional brain cells, called astrocytes, from embryonic stem cells.

NUS researchers confine mature cells to turn them into stem cells
Recent research led by Professor G.V. Shivashankar of the Mechanobiology Institute at the National University of Singapore and the FIRC Institute of Molecular Oncology in Italy, has revealed that mature cells can be reprogrammed into re-deployable stem cells without direct genetic modification -- by confining them to a defined geometric space for an extended period of time.

Researchers develop a new method for turning skin cells into pluripotent stem cells
Researchers at the University of Helsinki, Finland, and Karolinska Institutet, Sweden, have for the first time succeeded in converting human skin cells into pluripotent stem cells by activating the cell's own genes.

Read More: Stem Cells News and Stem Cells Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.